Take a good look at these Houston entrepreneurs' faces, because you might be seeing them in downtown Austin next weekend for SXSW. Photos courtesy

Welcome to a special edition of InnovationMap's weekly innovators to know series. This week has more innovators featured than ever, and we're highlighting a particular group of people: The Houston founders headed for SXSW in Austin later this week. From startup founders, coworking space leaders, and pitch competition organizers, here's the Houston SXSW attendees you should know about.

Scott Parazynski, CEO of Fluidity Technologies

Courtesy of Fluidity

Houston-based Fluidity Technologies and its drone controller, FT Aviator, will be presenting at the 11th annual SXSW Pitch event on Saturday, March 9, at 5 p.m. The company has been named a finalist in the Hyper-Connected Communities category. Fluidity is lead by CEO Scott Parazynski, a former NASA astronaut, pilot, and physician. The FT Aviator has the potential to revolutionize drone technology. The joystick-like controller is based off movement in space, Parazynski says, and is less prone to user error by someone not as well trained in drone operation.

Fluidity will find out if it wins in its category on Sunday, March 10, at 6:30 p.m. at the SXSW Pitch awards program.

Lawson Gow, founder and CEO of The Cannon

Courtesy of The Cannon

There's no better setting to talk Texas entrepreneurialism than a stage at SXSW, and that's what Lawson Gow, founder and CEO of The Cannon, is going to be doing on the "Austinpreneur: The Texas Startup Manifesto" panel presented by Capital Factory on Saturday, March 9, at 11 am.

Gow, who is the son of InnovationMap's parent company's CEO, has been juggling a lot since the launch of Cannon Ventures last year and the anticipation of The Cannon's new West Houston 120,000-square-foot facility, which is expected to deliver in May.

Gabriella Rowe, CEO of Station Houston

Courtesy of Station Houston

Gabriella Rowe, the fearless leader of startup acceleration hub, Station Houston, is headed for the state capital to talk, well, capital. Rowe will be a panelist on the "Startup Funding: From Apprenticeships to Professions" panel on Saturday, March 9, at 12:30 pm.

Rowe has served as CEO of Station Houston since August. The nonprofit has a lot going on ahead of The Ion's launch, of which the Station is the programming partner. Read more about that — and why Rowe says wild horses couldn't drag her out of Houston —in her Featured Innovator piece.

Katharine Forth, founder and CEO of Zibrio

Courtesy of Zibrio

Another Houston company selected as a finalist of the 11th annual SXSW Pitch event is Zibrio SmartScale, which is in the Health and Wearable category and is presenting on Sunday, March 10, at 5 pm. The company is all about balance. Its product, a smart scale that tracks balance, aims to reduce dangers that come with poor balance — injuries, deaths, and costs from falls. Katharine Forth leads the company as CEO and founder. The company was a member of TMCx's 2015 medical devices cohort.

Right after pitching, Forth will find out if her company wins in its category on Sunday, March 10, at 6:30 p.m. at the SXSW Pitch awards program.

Greg Wright, founder of HATCH Pitch

Courtesy of HATCH

For the eighth year, Houston-based HATCH Pitch is headed to Austin for SXSW to host its pitch competition focused on startups making the world a better place. Greg Wright, founder of the pitch program, will be there leading the event, which takes place on Monday, March 11, from 10 am to noon. The competition will be between four finalists. While only invited guests guests can attend, the pitches will be streamed online in an interactive way, so viewers can post comments or questions to the mentors, pitchers, and judges.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

European spacecraft developer expands to Houston with U.S. business, new lab

houston hq

European aerospace manufacturer The Exploration Company has established its first U.S. entity and named Space City as its headquarters.

The company announced earlier this month that it has launched TEC Federal to support U.S. government customers and agencies, and to scale The Exploration Company's engineering operations in the country.

Mark Kirasich serves as president of TEC Federal. Kirasich most recently served as the senior director of human spaceflight at Blue Origin after a nearly 40-year career at NASA.

The Exploration Company is developing the reusable Nyx space vehicle. Nyx is designed to take off from any heavy launcher in the world. It will then dock at space stations, retrieve up to 3,000 kilograms of cargo, splash down and return the cargo to Earth. The company aims to make Nyx fully reusable for up to 10 missions, making it a more affordable and sustainable option for aerospace missions.

The Exploration Company completed a successful drop test of the spacecraft in May in the Mojave Desert. The company says Nyx is slated to perform its first flight demonstration in 2028.

In addition to launching the Houston business, The Exploration Company also opened its new Rapid Innovation Lab near Houston's NASA Johnson Space Center on Space Park Drive.

The Exploration Company opened its Rapid Innovation Lab earlier this month. Photo via LinkedIn

The Rapid Innovation Lab features a full-scale mockup of the future Nyx crew capsule as well as ongoing development and testing of the Nyx cargo capsule, according to the company.

The Exploration Company says the new lab will allow its engineers, designers, and operators to prototype and test crew interfaces. It will also support partnerships with NASA personnel and astronauts.

“Houston gives us direct access to the people and expertise that have built and operated human spaceflight systems for decades. We’re excited to invest and expand around that— engineers, operators, and astronauts working together and moving quickly towards building a crew capsule.” Hélène Huby, founder and CEO of The Exploration Company, said in a blog post.

According to The Houston Chronicle, The Exploration Company has about 30 employees in the Houston area.

The company was founded in 2021 by Huby, a French rocket scientist, and has raised more than $350 million in venture capital. It operates out of Germany, France, Luxembourg, Spain and Italy, with offices in the U.S. and the United Arab Emirates. It is also developing a reusable, high-thrust rocket engine known as Storm.

UH lands $4M NIH grant to study early signs of autoimmune disease

NIH funding

The University of Houston recently received a $4 million National Institutes of Health grant to support a 10-year longitudinal study to identify the earliest biological markers of autoimmune disease.

Led by Chandra Mohan, the Hugh Roy and Lillie Cranz Cullen Endowed Professor of Biomedical Engineering, the study aims to examine what causes Systemic Autoimmune Rheumatic Diseases (SARDs) and to identify targets for future treatments. The study will be carried out in collaboration with Dr. Karen Costenbader at Harvard Medical School, Boston.

SARDs include conditions like rheumatoid arthritis, systemic lupus erythematosus, Sjögren’s syndrome and systemic sclerosis—all are considered chronic diseases currently without a cure. Autoimmune diseases affect over 30 million people globally, according to UH.

SARDs occur when the body’s immune system attacks healthy, non-threatening tissues and organs. According to UH, in these diseases, the body often attacks nuclear antigens, creating anti-nuclear autoantibodies, which can be early detection signs for SARDs in more than 50 percent of patients, Mohan says.

Researchers will study blood samples and environmental exposure over the 10 years to better understand anti-nuclear autoantibodies.

“Collectively, these studies will help identify the genetic, environmental and cellular factors that are operative at the two steps of SARD development, namely the emergence of anti-nuclear autoantibodies and disease onset,” Mohan said in a news release. “ More importantly, these studies will highlight functional molecular pathways and mechanisms that may be operative at each step."

Mohan predicts that looking at SARDs’ shared characteristics, rather than each disease individually, could help identify more treatment methods.

“Individual SARDs have been examined in silos without an attempt to discern shared underlying features at the molecular level,” he added in the release. “Current understanding of the initial (and likely shared) origins of SARDs is only rudimentary but urgently needed to develop means for prevention and treatment.”

Earlier this year, UH also received an $11 million NIH grant to conduct a first-of-its-kind study of early language development in children ages 18 to 24 months. Read more here.